Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Medicare Part D
Payers
Medicaid redeterminations still affecting Centene, stock plunges
Centene's stock sunk Wednesday after the company highlighted issues it faces surrounding Medicaid redeterminations.
Noah Tong
Sep 5, 2024 7:20am
Attorneys: Humana settles whistleblower suit for $90M
Aug 20, 2024 4:25am
Republicans challenge CMS premium stabilization program legality
Aug 8, 2024 12:30pm
Centene subsidiary WellCare to retreat from 6 states in 2025
Aug 7, 2024 3:02pm
Step therapy requirements could delay care for cancer patients
Jun 6, 2024 3:45pm
Payer Roundup—Elevance buys rival; Virginia plan under probe
Apr 17, 2024 3:30pm